Comparison of Methods of Pulmonary Blood Flow Augmentation in Neonates: Shunt Versus Stent (The COMPASS Trial) (COMPASS)
Sponsor: Carelon Research
A NA clinical study on Congenital Heart Disease in Children, this trial is ongoing. The trial is conducted by Carelon Research and has accumulated 13 data snapshots since 2022. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.
Status Flow
Change History
13 versions recorded-
Feb 2026 — Present [monthly]
Active Not Recruiting NA
-
Jan 2026 — Feb 2026 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
Sep 2025 — Jan 2026 [monthly]
Recruiting NA
-
Mar 2025 — Sep 2025 [monthly]
Recruiting NA
-
Sep 2024 — Mar 2025 [monthly]
Recruiting NA
▶ Show 8 earlier versions
-
Jul 2024 — Sep 2024 [monthly]
Recruiting NA
-
Aug 2023 — Jul 2024 [monthly]
Recruiting NA
-
May 2023 — Aug 2023 [monthly]
Recruiting NA
-
Mar 2023 — May 2023 [monthly]
Recruiting NA
-
Dec 2022 — Mar 2023 [monthly]
Recruiting NA
-
Sep 2022 — Dec 2022 [monthly]
Recruiting NA
-
Jul 2022 — Sep 2022 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Apr 2022 — Jul 2022 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Carelon Research
- Pediatric Heart Network
For direct contact, visit the study record on ClinicalTrials.gov .